RIZZO, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 2.687
EU - Europa 2.355
AS - Asia 2.247
SA - Sud America 191
AF - Africa 59
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.560
Nazione #
US - Stati Uniti d'America 2.592
SG - Singapore 695
GB - Regno Unito 689
CN - Cina 677
IT - Italia 506
DE - Germania 261
SE - Svezia 253
HK - Hong Kong 226
VN - Vietnam 223
RU - Federazione Russa 165
BR - Brasile 153
BD - Bangladesh 129
FR - Francia 104
FI - Finlandia 81
IN - India 76
NL - Olanda 73
CA - Canada 72
IE - Irlanda 56
DK - Danimarca 44
KR - Corea 43
JP - Giappone 40
ID - Indonesia 38
CI - Costa d'Avorio 35
TR - Turchia 33
UA - Ucraina 31
AU - Australia 18
BE - Belgio 18
IQ - Iraq 12
AR - Argentina 11
CH - Svizzera 10
MX - Messico 10
TW - Taiwan 10
PL - Polonia 9
AT - Austria 8
ES - Italia 8
GR - Grecia 8
ZA - Sudafrica 8
EC - Ecuador 7
RO - Romania 6
CL - Cile 5
PE - Perù 5
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
EG - Egitto 4
LT - Lituania 4
SC - Seychelles 4
EE - Estonia 3
EU - Europa 3
IR - Iran 3
JO - Giordania 3
MA - Marocco 3
MY - Malesia 3
NO - Norvegia 3
NP - Nepal 3
PH - Filippine 3
PY - Paraguay 3
UZ - Uzbekistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BO - Bolivia 2
CO - Colombia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
HN - Honduras 2
HR - Croazia 2
IL - Israele 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
PR - Porto Rico 2
SA - Arabia Saudita 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
CR - Costa Rica 1
GE - Georgia 1
JM - Giamaica 1
KE - Kenya 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
ME - Montenegro 1
MM - Myanmar 1
NG - Nigeria 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 7.563
Città #
Southend 617
Singapore 437
Ashburn 368
Hong Kong 214
Milan 200
Chandler 195
Houston 172
San Jose 154
Fairfield 147
Dallas 115
Beijing 114
Wilmington 104
Seattle 85
Council Bluffs 78
Ann Arbor 77
Woodbridge 68
Ho Chi Minh City 66
Princeton 58
Los Angeles 54
Santa Clara 54
Dublin 52
Helsinki 49
Toronto 45
Cambridge 44
Hefei 42
Hanoi 41
New York 37
Abidjan 35
Phoenix 32
Guangzhou 31
Munich 31
Bengaluru 30
Frankfurt am Main 30
Jakarta 30
Moscow 30
Shanghai 30
The Dalles 30
Buffalo 27
Lauterbourg 25
Des Moines 24
Dearborn 23
Nanjing 23
Boardman 22
Columbus 20
Cangzhou 19
Rome 19
São Paulo 19
Hanover 18
Seoul 18
Hangzhou 16
Istanbul 16
Mountain View 16
Tokyo 14
Redmond 13
Brussels 12
Grafing 12
Nanchang 12
Shenyang 12
Da Nang 11
Fuzhou 11
Redwood City 11
Washington 11
Changsha 10
Jinan 10
Nuremberg 10
Orem 10
Haiphong 9
Mumbai 9
Naples 9
Shenzhen 9
Tianjin 9
Berlin 8
London 8
Ottawa 8
Stockholm 8
Turku 8
Zhengzhou 8
Andover 7
Atlanta 7
Bitonto 7
Castelnuovo del Garda 7
Chengdu 7
Falls Church 7
Jiaxing 7
Philadelphia 7
Rho 7
Silver Spring 7
Taipei 7
Baghdad 6
Chennai 6
Chicago 6
Düsseldorf 6
Hebei 6
Roxbury 6
Warsaw 6
Boston 5
Brasília 5
Bridge 5
Denver 5
Dong Ket 5
Totale 4.697
Nome #
Key role of SMN/SYNCRIP and RNA-Motif 7 in spinal muscular atrophy: RNA-Seq and motif analysis of human motor neurons 421
Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model 416
GENERAZIONE DI IPSC COME MODELLO IN VITRO E SVILUPPO DI UN POSSIBILE APPROCCIO TERAPEUTICO PER LA MALATTIA DI CHARCHOT-MARIE-TOOTH DI TIPO 2A(CMT2A) 398
Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches 375
Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model 362
Neural stem cell transplantation for neurodegenerative diseases 340
IPSC-derived neural stem cells act via kinase inhibition to exert neuroprotective effects in spinal muscular atrophy with respiratory distress type 1 293
Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype 276
Animal Models of CMT2A: State-of-art and Therapeutic Implications 267
Downregulation of glutamic acid decarboxylase in Drosophila TDP- 43-null brains provokes paralysis by affecting the organization of the neuromuscular synapses 245
Synaptotagmin 13 is neuroprotective across motor neuron diseases 244
Disease Modeling and Therapeutic Strategies in CMT2A: State of the Art 220
Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model 219
Genome-wide RNA-seq and proteomic analysis of motor neurons indicates selective cytoskeletal perturbation in Brown-Vialetto disease, partially rescued by riboflavin 216
Direct reprogramming of human astrocytes into neural stem cells and neurons 212
Morpholino antisense oligomer against SOD1 for amyotrophic lateral sclerosis therapy 205
Clinical and genetic features of a cohort of patients with MFN2-related neuropathy 203
Peptide-conjugated Morpholino Oligomers for treatment of Spinal Muscular Atrophy 202
Stathmins and Motor Neuron Diseases: Pathophysiology and Therapeutic Targets 198
Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy 186
Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis 182
Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis 171
MFN2-related neuropathies: clinical features, molecular pathogenesis and therapeutic perspectives 171
Mitochondrial fusion proteins and human diseases 169
Genetic correction of spinal muscular atrophy-induced pluripotent stem cells and motoneurons as a disease model and cell source for transplantation 169
A model for motor neuron degeneration and treatment of Spinal Muscular Atrophy using human induced pluripotent stem cells 168
Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies 166
Selective mitochondrial depletion, apoptosis resistance, and increased mitophagy in human Charcot-Marie-Tooth 2A motor neurons 160
Targeted gene correction of spinal muscular atrophy induced pluripotent stem cells and motoneurons as cell source for therapy 158
Charcot-Marie-tooth disease type 2A: An update on pathogenesis and therapeutic perspectives 155
Effect of combined systemic and local morpholino treatment on the spinal muscular atrophy δ7 mouse model phenotype 154
Targeting STMN2 for neuroprotection and neuromuscular recovery in Spinal Muscular Atrophy: evidence from in vitro and in vivo SMA models 138
Investigating the prevalence of MFN2 mutations in amyotrophic lateral sclerosis: insights from an Italian cohort 135
Charcot-Marie-Tooth type 2A in vivo models: Current updates 130
Development of a therapeutic approach for Spinal Muscular Atrophy with Respiratory Distress (SMARD1) using human induced pluripotent stem cell-derived neural stem cells and motor neurons 111
Advances and challenges in modeling Charcot-Marie-Tooth type 2A using iPSC-derived models 49
null 4
null 3
null 3
null 3
null 3
null 3
null 3
null 3
null 3
Totale 7.912
Categoria #
all - tutte 19.943
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.943


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021125 0 0 0 0 0 0 0 0 0 0 49 76
2021/2022664 27 57 40 90 36 65 35 26 86 74 33 95
2022/2023637 92 95 51 63 61 94 38 26 82 9 16 10
2023/2024417 14 32 19 40 95 24 18 23 47 12 29 64
2024/20251.219 65 109 53 122 79 50 40 97 56 128 160 260
2025/20262.521 268 182 283 204 195 188 367 103 253 185 293 0
Totale 7.912